Suchergebnisse - "Matsunaga, Akihiro"

PubPharm (9)

1

A case of COVID-19 reinfection in a hemodialysis patient : the role of antibody in SARS-CoV-2 infection

enthalten in: CEN case reports | 2022

von Beppu, H. | Ogawa, T. | Ishikane, M. | +13

2

Prolonged SARS-CoV-2 infection associated with long-term corticosteroid use in a patient with impaired B-cell immunity

enthalten in: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy | 2022

von Morishita, M. | Suzuki, M. | Matsunaga, A. | +17

3

A case report of breakthrough infection with the SARS-CoV-2 delta variant and household transmission : Role of vaccination, anti-spike IgG and neutralizing activity

enthalten in: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy | 2022

von Moriyama, Y. | Ishikane, M. | Ueno, M. | +6

4

Antibody responses after two doses of SARS-CoV-2 mRNA-1273 vaccine in an individual with history of COVID-19 re-infection

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2022

von Inada, M. | Ishikane, M. | Terada, M. | +9

5

Isolation of human monoclonal antibodies with neutralizing activity to a broad spectrum of SARS-CoV-2 viruses including the Omicron variants

enthalten in: Antiviral research | 2022

von Ueno, M. | Iwata-Yoshikawa, N. | Matsunaga, A. | +20

6

Asymptomatic COVID-19 re-infection in a Japanese male by elevated half-maximal inhibitory concentration (IC50) of neutralizing antibodies

enthalten in: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy | 2021

von Inada, M. | Ishikane, M. | Terada, M. | +11

7

How we secured a COVID-19 convalescent plasma procurement scheme in Japan

enthalten in: Transfusion | 2021

von Terada, M. | Kutsuna, S. | Togano, T. | +36

8

Factors associated with anti-SARS-CoV-2 IgG antibody production in patients convalescing from COVID-19

enthalten in: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy | 2021

von Kutsuna, S. | Asai, Y. | Matsunaga, A. | +13

9

Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19

enthalten in: The New England journal of medicine | 2020

von Kutsuna, S. | Asai, Y. | Matsunaga, A.

CommentOn: N Engl J Med. 2020 Sep 10;383(11):1085-1087. - PMID 32706954

1
[1]